NAFDAC Approves Pfizer Covid-19 Vaccine in Nigeria

The National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria has approved the use of the Pfizer COVID-19 vaccine in the west African country.

The Pfizer vaccine becomes the second vaccine to be approved in the country following the authorisation of Oxford-Astrazeneca jabs few months ago.

Announcing this at a press conference in Lagos, the Director-General of NAFDAC, Mojisola Adeyeye, explained that the Pfizer-BioTech vaccine is for emergency use only.

She added that the vaccine can now be stored between -15oC to -25oC equivalent to freezer temperature.

The Africa CDC, has reported that 17.9 million COVID-19 doses have been administered, out of the over 37.1 million acquired by member states.

So far, Nigeria has administered 1.2 million COVID-19 vaccines, which amounts to 0.57 percent of the population fully vaccinated.

All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express written permission from News Central TV.


Exit mobile version